Site Announcement
For the latest results and update on CytoDyn’s Phase 2 CRC trial and more, here’s a link to our April 30, 2026 investor update webinar
| Date | Form | Description | XBRL | Pages | |
|---|---|---|---|---|---|
| 02/02/18 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 01/31/18 | SC TO-I/A | Issuer tender offer statement |
|
4 | |
| 01/31/18 | 424B5 | Prospectus filed pursuant to Rule 424(b)(5) |
|
60 | |
| 01/31/18 | 8-K | Current report filing |
|
35 | |
| 01/25/18 | SC TO-I/A | Issuer tender offer statement |
|
5 | |
| 01/23/18 | SC TO-I/A | Issuer tender offer statement |
|
4 | |
| 01/23/18 | 424B5 | Prospectus filed pursuant to Rule 424(b)(5) |
|
59 | |
| 01/23/18 | 8-K | Current report filing |
|
47 | |
| 01/10/18 | SC TO-I/A | Issuer tender offer statement |
|
4 | |
| 01/10/18 | 8-K | Current report filing |
|
3 |
